What did @therestoreclinic actually say?
The creator made three specific claims worth examining. First, that anyone still feeling bad after three years on TRT is "absolutely not dialed in properly." Second, that injecting less than twice a week means you'll "never get where you want to be." Third, that providers who test testosterone levels two to three days after an injection are chasing numbers rather than helping patients, and that some men stay symptomatic even with testosterone in the 400-500 ng/dL range.
These aren't fringe ideas. The symptom-versus-numbers debate is real in endocrinology and men's health medicine. But the way this is framed papers over a lot of clinical complexity, and at least one claim crosses from opinion into misinformation.
Does the science back this up?
The "treat symptoms, not numbers" argument has partial support in the literature, but the injection frequency claim is stated as absolute fact when the evidence is considerably more nuanced.
On injection frequency: testosterone cypionate and enanthate have half-lives of roughly 8 and 4-5 days respectively. Bhasin et al. (2010, New England Journal of Medicine) and subsequent pharmacokinetic modeling do support more frequent dosing to reduce peak-to-trough swings, which can drive side effects like mood instability, erythrocytosis, and estrogen fluctuations. More frequent dosing, such as twice weekly, does produce more stable serum levels. That part holds up.
On symptoms persisting in the "normal" range: research by Morgentaler et al. (2016, Mayo Clinic Proceedings) documented that hypogonadal men have widely varying symptom thresholds, and that population-based reference ranges don't capture individual sensitivity. This supports the idea that some men feel poorly at levels that look fine on a lab report. That part also holds up, cautiously.
What doesn't hold up: the claim that once-every-10-to-14-day dosing means you will never improve. Some formulations and some patients do reasonably well on biweekly schedules. Saying "never" here is simply not supported by evidence.
What did they get wrong (or right)?
They got the symptom argument mostly right, and credit is due for pushing back on reflexive lab-normal dismissals. A testosterone level of 450 ng/dL does not guarantee a man feels well. The Endocrine Society's own 2018 clinical practice guidelines (Bhasin et al., Journal of Clinical Endocrinology and Metabolism) acknowledge that symptom assessment should drive treatment decisions alongside biochemical data, not instead of it. That nuance matters.
Where this goes wrong:
- "Never get where you want to be" on less-frequent dosing is an absolute that isn't clinically defensible. Some patients on weekly or biweekly injections achieve stable levels and symptom resolution.
- The framing suggests providers ordering labs two to three days post-injection are acting in bad faith. In reality, trough testing (just before a dose) is standard protocol precisely because it gives a more reproducible and conservative estimate. Timing matters, and mid-cycle peaks are not the right time to test, but the intent behind structured testing schedules is not to gaslight patients.
- Calling out "providers who chase numbers" without acknowledging that symptoms alone can also mislead clinicians, since fatigue, libido issues, and low mood have many causes beyond testosterone, is a significant omission.
What should you actually know?
If you've been on TRT for years and still feel rough, this video identifies real possibilities worth raising with your provider. But it also oversimplifies a clinical picture that requires more than adjusting injection frequency.
A few things worth understanding:
- Injection timing for bloodwork matters enormously. Testing at peak, which happens 24-48 hours post-injection for most esters, inflates your apparent level. Trough testing, done just before your next dose, gives a more useful clinical picture. Neither approach is dishonest when used consistently.
- Persistent symptoms on TRT can reflect factors beyond testosterone levels, including low free testosterone due to high SHBG, suboptimal hematocrit, thyroid dysfunction (notably the hypothyroidism hashtag in this video), sleep apnea, or depression. A single-variable fix often isn't enough.
- The Endocrine Society guidelines do support symptom-guided management, but they also warn against treating men who fall within normal reference ranges without a confirmed diagnosis of hypogonadism. There are real risks to over-treatment, including erythrocytosis, cardiovascular effects, and suppression of natural production.
- "Dialed in properly" is not a standardized clinical term, and what feels dialed in varies significantly between individuals. If you are not improving, the answer may be injection frequency, or it may be something else entirely that labs would actually help identify.
Bottom line
This video makes a legitimate point about symptom-focused care, then undermines it with overconfident absolutes. The injection frequency advice is directionally reasonable for many patients, but stating it as universal law is not honest medicine. Talk to a provider who does both: listens to your symptoms and interprets your labs with proper timing and context. One without the other is incomplete care.